Search Results 231-240 of 17271 for Proto-oncogene
All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...
Pazopanib hydrochloride may also stop the growth of kidney cancer by blocking blood flow to the tumor. Participation eligibility. Participant eligibility ...
About this study. The purpose of this is to evaluate the safety, effectivess, pharmacokinetics, and pharmacodynamics of FT-2102 as a single agent and in ...
ROCHESTER, Minn. — For many people living with cancer, symptoms such as pain, anxiety or insomnia can quickly spiral into an emergency room visit. Such[...] ...
See posters, presentations and video from Dr. Ertekin-Taner's Genetics of Alzheimer's Disease and Endophenotypes Lab at Mayo Clinic's campus in Florida.
The purpose of this study is to provide expanded access for patients with cancer with RET activation who are ineligible for an ongoing LOXO-292 clinical trial ...
This surgical technique can help surgeons find and remove cancerous tissue in real-time during surgeries.
The primary aim of this study is to determine if the addition of an individual polygenic risk score (PRS) in addition to the Breast Cancer Risk Assessment Tool ...
Research · Breast cancer and ovarian cancer · Colon Cancer Family Registry · Congenital disorders of glycosylation · Familial Cancer Program · Familial melanoma.
Romidepsin and lenalidomide may stop the growth of cancer cells by blocking enzymes needed for cell growth. Giving rituximab together with romidepsin and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.